PMC:7441788 / 725-1152
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T10 | 18-26 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T11 | 131-139 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T12 | 302-310 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T4 | 28-29 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T5 | 251-252 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T10 | 88-90 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T11 | 215-217 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T12 | 253-262 | Chemical | denotes | macrolide | http://purl.obolibrary.org/obo/CHEBI_25106 |
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T7 | 88-90 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T8 | 215-217 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T9 | 253-262 | Chemical | denotes | macrolide | http://purl.obolibrary.org/obo/CHEBI_25106 |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T8 | 18-26 | Species | denotes | COVID-19 | NCBItxid:2697049 |
T9 | 131-141 | Species | denotes | SARS-CoV-2 | NCBItxid:2697049 |
T10 | 302-310 | Species | denotes | COVID-19 | NCBItxid:2697049 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T12 | 28-177 | Sentence | denotes | A number of in vitro studies revealed inhibitory effects of CQ/HCQ on various coronaviruses, including SARS-CoV-2 although conflicting results exist. |
T13 | 178-403 | Sentence | denotes | Several clinical studies showed that CQ/HCQ alone or in combination with a macrolide may alleviate the clinical symptoms of COVID-19, promote viral conversion, and delay disease progression, with less serious adverse effects. |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
40 | 215-221 | Gene | denotes | CQ/HCQ | |
44 | 106-119 | Species | denotes | coronaviruses | Tax:11118 |
45 | 131-141 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
52 | 88-90 | Chemical | denotes | CQ | MESH:D002738 |
53 | 91-94 | Chemical | denotes | HCQ | MESH:D006886 |
54 | 253-262 | Chemical | denotes | macrolide | MESH:D018942 |
67 | 18-26 | Disease | denotes | COVID-19 | MESH:C000657245 |
68 | 302-310 | Disease | denotes | COVID-19 | MESH:C000657245 |
69 | 342-355 | Disease | denotes | delay disease | MESH:D003141 |
LitCovid-sample-PD-IDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 290-298 | http://purl.obolibrary.org/obo/OGMS_0000020 | denotes | symptoms |
T4 | 348-355 | http://purl.obolibrary.org/obo/OGMS_0000031 | denotes | disease |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T8 | 18-26 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T9 | 131-141 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T10 | 302-310 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
40 | 215-221 | Gene | denotes | CQ/HCQ | |
44 | 106-119 | Species | denotes | coronaviruses | Tax:11118 |
45 | 131-141 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
52 | 88-90 | Chemical | denotes | CQ | MESH:D002738 |
53 | 91-94 | Chemical | denotes | HCQ | MESH:D006886 |
54 | 253-262 | Chemical | denotes | macrolide | MESH:D018942 |
67 | 18-26 | Disease | denotes | COVID-19 | MESH:C000657245 |
68 | 302-310 | Disease | denotes | COVID-19 | MESH:C000657245 |
69 | 342-355 | Disease | denotes | delay disease | MESH:D003141 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T12 | 28-177 | Sentence | denotes | A number of in vitro studies revealed inhibitory effects of CQ/HCQ on various coronaviruses, including SARS-CoV-2 although conflicting results exist. |
T13 | 178-403 | Sentence | denotes | Several clinical studies showed that CQ/HCQ alone or in combination with a macrolide may alleviate the clinical symptoms of COVID-19, promote viral conversion, and delay disease progression, with less serious adverse effects. |